Double maintains 2 strategies that include RPTX - Repare Therapeutics, Inc.
Current Value
$1.201 Year Return
Current Value
$1.201 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTG | 0.09% | $1.73B | 0.07% |
OILK | -0.20% | $73.97M | 0.69% |
CLOI | 0.24% | $911.21M | 0.4% |
DBE | -0.45% | $56.04M | 0.77% |
IVOL | 0.54% | $437.42M | 1.02% |
IYK | 0.72% | $1.29B | 0.4% |
DBO | -0.73% | $191.98M | 0.77% |
UGA | 0.76% | $93.86M | 0.97% |
GBIL | 0.77% | $5.76B | 0.12% |
SCHO | 0.80% | $11.46B | 0.03% |
CLOA | -0.85% | $710.77M | 0.2% |
XBIL | 1.01% | $664.34M | 0.15% |
USL | -1.03% | $49.89M | 0.85% |
TBIL | -1.05% | $4.82B | 0.15% |
BNO | 1.13% | $94.01M | 1% |
BILZ | -1.22% | $760.23M | 0.14% |
TBLL | 1.36% | $2.04B | 0.08% |
SPTS | 1.44% | $5.80B | 0.03% |
USO | 1.47% | $1.12B | 0.6% |
GCC | -1.49% | $142.85M | 0.55% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EDIT | 36.44% | $101.53M | -85.20% | 0.00% |
SFIX | 34.26% | $693.83M | +37.44% | 0.00% |
LPX | 33.06% | $7.89B | +60.29% | 0.92% |
IMNM | 32.49% | $883.16M | -53.69% | 0.00% |
FFIC | 32.21% | $501.18M | +10.21% | 5.93% |
POWI | 31.92% | $3.40B | -20.99% | 1.35% |
CVCO | 31.55% | $4.29B | +44.37% | 0.00% |
MTH | 31.09% | $5.32B | -6.09% | 4.03% |
TMHC | 31.05% | $6.62B | +11.70% | 0.00% |
ARCT | 30.68% | $444.50M | -57.03% | 0.00% |
BLD | 29.98% | $9.65B | -17.30% | 0.00% |
PLTK | 29.92% | $2.78B | -3.99% | 5.34% |
TPH | 29.60% | $3.37B | +0.03% | 0.00% |
BCC | 29.54% | $4.63B | -12.23% | 0.68% |
KBH | 29.51% | $4.63B | +1.74% | 1.54% |
SKY | 29.12% | $6.19B | +33.70% | 0.00% |
HOV | 29.00% | $793.90M | -20.29% | 0.00% |
CRSP | 28.95% | $3.73B | -48.52% | 0.00% |
HCSG | 28.83% | $828.92M | -8.94% | 0.00% |
MHO | 28.80% | $3.21B | -5.46% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ES | -0.01% | $22.90B | +6.62% | 4.56% |
ACCD | -0.01% | $565.00M | -47.49% | 0.00% |
UTHR | 0.05% | $16.54B | +72.67% | 0.00% |
SOC | -0.12% | $2.73B | +146.82% | 0.00% |
PHI | -0.13% | $5.00B | +0.30% | 7.31% |
SRE | 0.18% | $53.12B | +18.95% | 2.94% |
KMB | 0.20% | $45.14B | +13.95% | 3.63% |
SO | -0.26% | $95.08B | +29.85% | 3.28% |
QNTM | 0.27% | $20.44M | -80.61% | 0.00% |
MMC | -0.29% | $113.50B | +14.98% | 1.37% |
RSG | 0.31% | $70.30B | +24.81% | 0.98% |
AQB | -0.33% | $2.90M | -69.38% | 0.00% |
MOH | 0.35% | $15.02B | -32.02% | 0.00% |
DK | 0.37% | $1.10B | -39.27% | 5.70% |
OPFI | 0.37% | $1.12B | +264.30% | 0.00% |
VZ | 0.37% | $172.76B | +1.11% | 6.52% |
DAKT | -0.39% | $747.33M | +103.72% | 0.00% |
BLCO | 0.43% | $5.86B | +16.85% | 0.00% |
TKC | 0.44% | $6.54B | +37.43% | 2.77% |
UUU | 0.44% | $4.91M | +50.71% | 0.00% |
Yahoo
Repare Therapeutics (RPTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Yahoo
Repare Therapeutics (RPTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Yahoo
CAMBRIDGE, Mass. & MONTREAL, January 09, 2025--Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
Yahoo
Repare Therapeutics (RPTX) reported Thursday results from a phase 1 trial of cancer drugs lunreserti
Yahoo
On Thursday, Repare Therapeutics Inc (NASDAQ:RPTX) revealed data from its MYTHIC Phase 1 gynecologic expansion trial evaluating the combination of lunresertib and camonsertib (Lunre+Camo) for endometrial cancer and platinum-resistant ovarian cancer (PROC) harboring lunre-sensitizing biomarkers. As of the data cut-off date of November 14, 51 evaluable patients were enrolled in the gynecologic cancer expansion cohort of the MYTHIC trial. Across all tumor types treated at the optimized RP2D (n=67),
Yahoo
Repare announced plans to initiate a Phase 3 registrational study for endometrial cancer in the second half of 2025.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 38.78% | $50.86M | 0.69% |
GNOM | 33.06% | $65.99M | 0.5% |
XPH | 32.50% | $164.02M | 0.35% |
PRNT | 31.97% | $90.56M | 0.66% |
ARKG | 31.72% | $1.19B | 0.75% |
IWC | 31.40% | $956.01M | 0.6% |
IBB | 31.19% | $6.33B | 0.45% |
XBI | 31.01% | $5.92B | 0.35% |
PBE | 30.23% | $245.59M | 0.58% |
ESML | 29.93% | $1.93B | 0.17% |
SMMD | 29.86% | $1.40B | 0.15% |
XHB | 29.78% | $1.76B | 0.35% |
VTWO | 29.76% | $11.72B | 0.07% |
IWO | 29.75% | $12.47B | 0.24% |
VBK | 29.70% | $20.12B | 0.07% |
ISCG | 29.66% | $665.64M | 0.06% |
IWM | 29.61% | $72.71B | 0.19% |
XRT | 29.55% | $347.21M | 0.35% |
NUSC | 29.52% | $1.26B | 0.31% |
IJT | 29.50% | $6.52B | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -24.47% | $277.56M | 1.43% |
VIXY | -16.29% | $195.31M | 0.85% |
DBA | -11.31% | $897.78M | 0.93% |
DUSB | -11.28% | $1.05B | 0.15% |
TAIL | -10.92% | $62.82M | 0.59% |
TFLO | -7.62% | $6.53B | 0.15% |
ULST | -6.73% | $558.12M | 0.2% |
WEAT | -6.45% | $125.72M | 0.28% |
USDU | -6.25% | $282.00M | 0.5% |
GOVZ | -6.11% | $286.59M | 0.1% |
EQLS | -5.37% | $7.90M | 1% |
BOXX | -5.23% | $5.04B | 0.1949% |
UUP | -4.71% | $389.72M | 0.77% |
BIL | -4.66% | $37.22B | 0.1356% |
CTA | -4.44% | $681.78M | 0.76% |
TPMN | -4.11% | $34.10M | 0.65% |
SGOV | -3.94% | $33.82B | 0.09% |
CCOR | -3.49% | $71.02M | 1.18% |
CARY | -2.39% | $347.36M | 0.8% |
USCI | -2.29% | $215.20M | 1.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
STG | -12.35% | $35.60M | -18.31% | 0.00% |
AVGO | -9.97% | $1.11T | +86.39% | 5.05% |
INSP | -9.75% | $5.55B | -2.90% | 0.00% |
CLRB | -9.23% | $12.95M | -92.17% | 0.00% |
CME | -8.99% | $90.13B | +18.52% | 4.18% |
LPTH | -8.88% | $113.05M | +78.13% | 0.00% |
TASK | -8.37% | $1.39B | +24.10% | 0.00% |
PGR | -8.32% | $153.56B | +38.52% | 1.88% |
DV | -8.08% | $3.89B | -44.85% | 0.00% |
MESO | -7.50% | $2.34B | +801.22% | 0.00% |
CBOE | -7.17% | $21.80B | +11.92% | 1.14% |
PG | -7.16% | $401.02B | +8.92% | 2.43% |
CYCN | -7.04% | $8.21M | +4.81% | 0.00% |
UNH | -6.89% | $488.84B | +1.98% | 1.55% |
CL | -6.65% | $71.69B | +5.00% | 2.32% |
K | -6.46% | $28.34B | +48.42% | 2.75% |
COR | -6.46% | $47.42B | +4.91% | 0.64% |
QTTB | -6.38% | $32.64M | -79.32% | 0.00% |
LW | -6.14% | $8.17B | -44.68% | 2.52% |
MASI | -5.91% | $9.62B | +33.88% | 0.00% |